Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Protagonist Therapeutics (PTGX) Ownership Overview
1.72% Insiders
15.16% Mutual Funds
50.31% Other Institutional Investors
22.69% ETFs
10.11% Public Companies and Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 88.16% of the company’s stock is owned by Institutional Investors, 1.72% is owned by Insiders, and 10.11% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 11, 2025 | xxxxxxxxxxxxx | $1125400 | |
Apr 23, 2025 | xxxxxxxxxxxxx | $80776 | |
Mar 14, 2025 | xxxxxxxxxxxxx | $1700850 | |
Mar 14, 2025 | xxxxxxxxxxxxx | $1462553 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $592651 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2538900 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $11368130 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $43412723 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,801,188 | Institution | 10.97% | 371,752,936 | |
| 6,107,006 | Institution | 9.85% | 333,808,948 | |
| 3,703,853 | Institution | 5.98% | 202,452,605 | |
| 2,878,214 | Institution | 4.64% | 157,323,177 | |
| 1,400,142 | Institution | 2.26% | 76,531,762 | |
| 1,091,271 | Institution | 1.76% | 59,648,873 | |
| 1,019,104 | Institution | 1.64% | 55,704,225 | |
| 931,890 | Institution | 1.50% | 50,937,107 | |
| 897,699 | Institution | 1.45% | 49,068,227 | |
| 622,971 | Institution | 1.01% | 34,051,595 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,878,214 | Institution | 4.64% | 157,323,177 | |
| 1,019,104 | Institution | 1.64% | 55,704,225 | |
| 622,971 | Institution | 1.01% | 34,051,595 | |
| 594,493 | Institution | 0.96% | 32,494,987 | |
| 423,913 | Institution | 0.68% | 23,171,085 | |
| 403,401 | Institution | 0.65% | 22,049,899 | |
| 345,217 | Institution | 0.56% | 18,869,561 | |
| 326,243 | Institution | 0.53% | 17,832,442 | |
| 279,435 | Institution | 0.45% | 15,273,917 | |
| 216,046 | Institution | 0.35% | 11,809,074 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,562,854 | Institution | 5.75% | 194,745,600 | |
| 1,972,956 | Institution | 3.18% | 93,656,221 | |
| 1,475,361 | Institution | 2.38% | 80,643,232 | |
| 926,592 | Institution | 1.49% | 43,985,322 | |
| 530,123 | Institution | 0.86% | 28,976,523 | |
| 511,567 | Institution | 0.83% | 27,962,252 | |
| 507,004 | Institution | 0.82% | 28,579,815 | |
| 475,528 | Institution | 0.77% | 26,805,513 | |
| 358,039 | Institution | 0.58% | 19,570,412 | |
| 354,045 | Institution | 0.57% | 19,352,100 |
FAQ
Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 50.31% of the company's stock is held by institutional investors, 1.72% is held by insiders, and 10.11% is held by retail investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.31% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 10.11% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
Who owns the most shares of Protagonist Therapeutics (PTGX)?
iShares owns the most shares of Protagonist Therapeutics (PTGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.